Table 2 of Liu, Mol Vis 2020; 26:378-391.


Table 2. The potentially disease-causing variants (PDVs) in POAG as compared with control.

Gene No. with PDVs in POAG (n=235) No. with PDVs in control (n=241) p-value Odds Ratio Cases:Cont (95% Cl)
ABCA1 6 (2.6) 7 (3.0) 1 0.88 (0.24-3.10)
ABO 2 (0.9) 0 (0) 0.4989 -
AFAP1 3 (1.3) 0 (0) 0.1203 -
APOE 4 (1.7) 1 (0.4) 0.211 4.14 (0.41-205.29)
ASB10 3 (1.3) 2 (0.9) 1.5439 0.58 (0.18-18.63)
ATXN2 8 (3.4) 0 (0) 0.0033 -
CDKN2B 5 (2.1) 0 (0) 0.0287 -
CYP1B1 1 (0.4) 1 (0.4) 1 1.03 (0.01-80.79)
EFEMP1 5 (2.1) 1 (0.4) 0.1184 5.20 (0.58-247.49)
FNDC3B 4 (1.7) 0 (0.4) 0.0586 -
FOXC1 6 (2.6) 0 (0.4) 0.014 -
GAS7 5 (2.1) 1 (0.4) 0.1184 5.20 (0.58-247.49)
LOXL1 6 (2.6) 1 (0.4) 0.0648 -
MYOC 6 (2.6) 0 (0) 0.014 -
OPTN 2 (0.9) 2 (0.9) 0.6195 1.03 (0.11-121.95)
PAK7 3 (1.3) 2 (0.9) 0.6235 0.68 (0.18-18.63)
PAX6 2 (0.9) 1 (0.4) 0.6195 2.06 (0.11-121.95)
PITX2 4 (1.7) 0 (0.4) 0.0586 -
TMCO1 1 (0.4) 0 (0) 0.4937 -
TXNRD2 8(3.4) 1 (0.4) 0.019 7.34 (0.1-376.19)
WDR36 3 (1.3) 1 (0.4) 0.3672 3.10 (0.25-163.45)